GT198170557A - 9-amino-1-hidroxioctahidrobenzo (c) quinolinas y sus deriva-dos. - Google Patents

9-amino-1-hidroxioctahidrobenzo (c) quinolinas y sus deriva-dos.

Info

Publication number
GT198170557A
GT198170557A GT198170557A GT198170557A GT198170557A GT 198170557 A GT198170557 A GT 198170557A GT 198170557 A GT198170557 A GT 198170557A GT 198170557 A GT198170557 A GT 198170557A GT 198170557 A GT198170557 A GT 198170557A
Authority
GT
Guatemala
Prior art keywords
derivatives
hydroxioctahidrobenzo
quinolines
amino
refers
Prior art date
Application number
GT198170557A
Other languages
English (en)
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT198170557A publication Critical patent/GT198170557A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
GT198170557A 1980-07-28 1981-07-21 9-amino-1-hidroxioctahidrobenzo (c) quinolinas y sus deriva-dos. GT198170557A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/173,207 US4309545A (en) 1980-07-28 1980-07-28 Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof

Publications (1)

Publication Number Publication Date
GT198170557A true GT198170557A (es) 1983-01-12

Family

ID=22630983

Family Applications (1)

Application Number Title Priority Date Filing Date
GT198170557A GT198170557A (es) 1980-07-28 1981-07-21 9-amino-1-hidroxioctahidrobenzo (c) quinolinas y sus deriva-dos.

Country Status (29)

Country Link
US (1) US4309545A (enExample)
EP (1) EP0045171B1 (enExample)
JP (1) JPS57112372A (enExample)
KR (1) KR850000273B1 (enExample)
AR (1) AR230988A1 (enExample)
AT (1) ATE11775T1 (enExample)
AU (1) AU525944B2 (enExample)
CA (1) CA1178274A (enExample)
CS (1) CS228515B2 (enExample)
DD (1) DD202012A5 (enExample)
DE (1) DE3168891D1 (enExample)
DK (1) DK334581A (enExample)
EG (1) EG15535A (enExample)
ES (1) ES8301926A1 (enExample)
FI (1) FI812338A7 (enExample)
GR (1) GR75283B (enExample)
GT (1) GT198170557A (enExample)
HU (1) HU185133B (enExample)
IE (1) IE51426B1 (enExample)
IL (1) IL63423A0 (enExample)
IN (1) IN158867B (enExample)
NO (2) NO812557L (enExample)
NZ (1) NZ197856A (enExample)
PH (1) PH17281A (enExample)
PL (1) PL133928B1 (enExample)
PT (1) PT73440B (enExample)
SU (1) SU1217254A3 (enExample)
YU (1) YU185181A (enExample)
ZA (1) ZA815128B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920221A (en) * 1982-03-16 1990-04-24 Pfizer Inc. Substituted decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines
US4642373A (en) * 1982-03-16 1987-02-10 Pfizer Inc. Substituted dodecahydrotripheylenes, and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US4473704A (en) * 1982-03-16 1984-09-25 Pfizer Inc. Substituted dodecahydrotriphenylenes, decahydro-1H-cyclopenta[1]phenanthrenes, decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US5605906A (en) * 1995-03-24 1997-02-25 Merck Frosst Canada, Inc. Cannabinoid receptor agonists
KR100454781B1 (ko) * 1996-01-31 2005-04-08 알타나 파마 아게 신규한페난트리딘
US6127378A (en) * 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
EP0889886B1 (de) * 1996-03-26 2002-09-18 ALTANA Pharma AG Neue in 6-position substituierte phenanthridine
US5776482A (en) * 1996-03-29 1998-07-07 University Of Iowa Research Foundation Tetrahydroquinoline analogues for use in glaucoma treatment
ATE224372T1 (de) * 1997-07-25 2002-10-15 Altana Pharma Ag Substituierte 6-alkylphenanthridine
US6121279A (en) * 1997-07-25 2000-09-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituted 6-phenylphenanthridines
AU3910700A (en) 1999-03-22 2000-10-09 Immugen Pharmaceuticals, Inc. Treatment of immune diseases
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US20060084021A1 (en) * 2004-09-10 2006-04-20 Kubicek Chris A Wick holder
WO2002026728A2 (en) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
WO2002026224A2 (en) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
WO2003080043A1 (en) * 2002-03-18 2003-10-02 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
AU2005247480A1 (en) * 2004-05-25 2005-12-08 Qlt Inc. Oculoselective drugs and prodrugs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839441A (en) * 1969-10-27 1974-10-01 Hoffmann La Roche Intermediates for partially hydrogenated phenanthridines
US3878219A (en) * 1973-07-13 1975-04-15 Abbott Lab 5H-{8 1{9 benzopyrano{8 3,4-d{9 pyridines
US3928598A (en) * 1973-11-05 1975-12-23 Lilly Co Eli Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
HU180916B (hu) 1976-05-17 1983-05-30 Pfizer Eljárás benzo[c]kinolin-származékok előállítására
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4152450A (en) * 1978-02-17 1979-05-01 Eli Lilly And Company 9-Amino-dibenzopyrans

Also Published As

Publication number Publication date
JPS57112372A (en) 1982-07-13
IE51426B1 (en) 1986-12-24
FI812338L (fi) 1982-01-29
CS228515B2 (en) 1984-05-14
AR230988A1 (es) 1984-08-31
DE3168891D1 (en) 1985-03-28
AU525944B2 (en) 1982-12-09
KR830006217A (ko) 1983-09-20
PH17281A (en) 1984-07-06
NO812557L (no) 1982-01-29
NO854454L (no) 1985-01-29
PL133928B1 (en) 1985-07-31
HU185133B (en) 1984-12-28
AU7343481A (en) 1982-05-06
IE811686L (en) 1982-01-28
NZ197856A (en) 1984-10-19
YU185181A (en) 1983-12-31
EP0045171A3 (en) 1982-04-28
GR75283B (enExample) 1984-07-13
EP0045171A2 (en) 1982-02-03
EP0045171B1 (en) 1985-02-13
KR850000273B1 (ko) 1985-03-15
ZA815128B (en) 1982-07-28
PT73440B (en) 1983-06-20
ES504323A0 (es) 1982-12-16
IL63423A0 (en) 1981-10-30
PT73440A (en) 1981-08-01
PL232331A1 (en) 1983-09-26
CA1178274A (en) 1984-11-20
FI812338A7 (fi) 1982-01-29
DK334581A (da) 1982-01-29
SU1217254A3 (ru) 1986-03-07
US4309545A (en) 1982-01-05
EG15535A (en) 1986-09-30
ES8301926A1 (es) 1982-12-16
DD202012A5 (de) 1983-08-24
ATE11775T1 (de) 1985-02-15
IN158867B (enExample) 1987-02-07

Similar Documents

Publication Publication Date Title
GT198170557A (es) 9-amino-1-hidroxioctahidrobenzo (c) quinolinas y sus deriva-dos.
AR002705A1 (es) Un nuevo compuesto de indolina, un proceso para su preparacion y composiciones farmaceuticas que lo contienen.
ES2132105T3 (es) 2-aminometil-cromanos como principios activos en farmacos para el tratamiento de enfermedades del sistema nervioso central.
GT199700079A (es) Derivados triciclos sustituidos con fenilamino
ES2092113T3 (es) Derivados fluoroalcoxibencilamino de heterociclos que contienen nitrogeno.
ES8504140A1 (es) Procedimiento para la preparacion de nuevos bencimidazoles substituidos
GT199700033A (es) Derivados de 6-fenilpiridil-2-amina.
ES2127946T3 (es) Antagonistas de neurocinina diazabiciclica.
ES2093979T3 (es) Esteres nitricos de derivados del acido 2-(2,6-dihalofenilamino)fenilacetico y su procedimiento de preparacion.
ES2053763T3 (es) Composiciones estabilizadas de isotiazolonas.
ECSP034656A (es) Derivados benzimidazol y piridilimidazol como ligandos para gabaa
MX9301348A (es) Nuevos compuestos que tienen actividad farmacologica, proceso para su preparacion y composicion farmaceutica que los comprende.
ES2064667T3 (es) Derivados de 3-aminopiperidina y heterociclos relacionados que contienen nitrogeno.
ES2164657T3 (es) Derivados aza-biciclicos puenteados como antagonistas de la sustancia p.
ES2163407T3 (es) Derivados piperidinilos tiaciclicos.
GT199800032A (es) 2-amino-6-(4-fenoxi-2-sustituido)-piridinas sustituidas.
PA8457001A1 (es) Derivados del 2-(4-aril o heteroaril-piperazin-i-ilmetil)-1h-indol
DE3677868D1 (de) Verfahren zur fluoreszenzloeschung und neue kationische naphthalin-peri-dicarbonsaeureimid-derivate.
ES2001923A6 (es) Procedimiento para preparar 3-amino-dihidro-(1)-benzo(tio)piranos.
ES2170798T3 (es) Benzopiranos y su uso como agentes terapeuticos.
ATE188873T1 (de) Tris-platin-komplexe
ES2081834T3 (es) Pirrolidin-2-onas 4-metil y 4-etil sustituidas.
ES2173435T3 (es) Derivados condensados de 2,3-benzodiazepinas y su utilizacion como agentes inhibidores de receptores de ampa.
GT197225694A (es) Agentes para el control de organismos patogenos de las plantas.
ES8504807A1 (es) Procedimiento para preparar nuevas 4-fenil-tetrahidrofurano (2, 3-c) piridinas